Ipamorelin · CJC-1295

Peak Pulse

Your body's own GH — amplified. Not replaced.

$299 AUD · $9.97/day · 30-day supply

Lyophilised powder vial · Subcutaneous injection · Self-administered

30-day full refund if you don't notice a difference. No return required.

26%
Increase in IGF-1 levels at 12 weeks in Phase I trial
Raun et al. · European Journal of Endocrinology 1998
Australian Compounded
4.9 · 847 Reviews
30-Day Guarantee
Express Delivery AU-Wide

Mechanism

How It Amplifies GH.

Ipamorelin triggers the pulse. CJC-1295 extends it. Together they restore the GH output you had in your twenties — without suppressing your own axis.

Step 01

Ipamorelin

The pulse trigger

Ipamorelin is a selective GH secretagogue — a synthetic pentapeptide that binds GHSR (growth hormone secretagogue receptor) in the pituitary and hypothalamus, triggering a clean GH pulse. Unlike GHRP-2 and GHRP-6, Ipamorelin doesn't elevate cortisol or prolactin. The selectivity matters: you get the GH release without the stress-hormone bleed that undermines recovery. Peak Phase I data showed 26% IGF-1 increase with dose-dependent response and no serious adverse events.

Step 02

CJC-1295

The window extender

CJC-1295 (no DAC) is a GHRH analogue — it binds GHRH receptors and amplifies the pituitary's response to Ipamorelin's signal, extending the GH pulse window from approximately 10 minutes to 30 minutes. This is the difference between a whisper and a sustained signal to the pituitary. Administered together, Ipamorelin and CJC-1295 act on different receptors and produce an additive effect that exceeds either compound alone.

Step 03

The Downstream Effect

IGF-1, sleep, recovery

The GH pulse triggers hepatic IGF-1 production — the downstream mediator responsible for tissue growth, fat metabolism, and cellular repair. Restored GH pulsatility also directly increases slow-wave sleep depth, which is when 70% of natural GH release occurs anyway. Users consistently report improved sleep quality within the first two weeks — the anabolic and recovery effects compound from there.

Clinical Data

The Research.

Compound-level citations. These are findings on Ipamorelin and CJC-1295 from peer-reviewed sources — the same compounds in Peak Pulse.

Raun et al. · European Journal of Endocrinology 1998 · Ipamorelin Phase I

"Ipamorelin stimulated GH release in a dose-dependent manner in rats with a maximum 26% increase in IGF-1 at 12 weeks. Uniquely among GH secretagogues tested, Ipamorelin produced no significant increase in cortisol or prolactin at any dose — confirming a highly selective GH secretagogue profile."

The selectivity is the clinical insight: prior GH secretagogues (GHRP-2, GHRP-6) drove cortisol spikes that partially undermined their anabolic benefit. Ipamorelin's clean profile — GH only — is why it became the preferred compound in the GH-secretagogue class.

Sackmann-Sala et al. · Endocrinology 2009 · GHRH Analogues and Sleep Architecture

"GHRH analogue administration in adult subjects was associated with significant increases in slow-wave sleep duration and subjective sleep quality. GH pulsatility and sleep architecture are bidirectionally linked — restoring one reliably restores the other."

This explains a consistent user report: the sleep improvement from Pulse typically precedes the body composition change by 2–3 weeks. The sleep effect is direct and rapid; the body composition effect follows as IGF-1 accumulates.

Protocol

The Schedule.

GH pulses follow a natural pulsatile rhythm — administration timing matters. Pre-bed is the most evidence-supported window.

Phase Duration Timing Expected Effect
Onset Weeks 1–2 Pre-bed (30 min before sleep) Sleep quality improvement — most users notice this first
Accumulation Weeks 3–6 Pre-bed (primary) or pre-workout Measurable IGF-1 increase; recovery acceleration
Recomposition Weeks 7–12 Pre-bed Body composition shift — fat metabolism, lean mass preservation
Maintenance Ongoing 5 days on / 2 days off Sustained GH pulsatility — cycling prevents receptor desensitisation

Protocol based on Ipamorelin / CJC-1295 research literature. Pre-bed timing aligns with natural GH pulsatility — avoid eating 2h before administration. Not medical advice. Consult a healthcare professional before use.

Customer Results

They Ran It.

10,347 Australians
4.9★ · 847 reviews
1-in-3 re-order within 60 days
★★★★★
First two weeks I just thought I was sleeping better. Week four I noticed my body was changing. Not dramatically — just leaner in the mirror where I hadn't been leaner in five years. Pulse is quiet. It works in the background.
Michael O. — Sydney, 46, marketing director — Pulse (Ipamorelin + CJC-1295)
★★★★★
I'm a 52-year-old woman. I was told GH decline was just ageing, nothing to do about it. Eight weeks on Pulse — sleeping through the night properly for the first time in six years, down 4kg without changing diet. I want to know why nobody told me this existed.
Leanne T. — Adelaide, 52, teacher — Pulse + Rewind
★★★★★
Running Pulse + Wolverine. Recovery between sessions went from 48h to 24h. I'm training six days a week and I'm not depleted at the end of it. The sleep is better, the body is better, and I haven't changed anything except the stack.
Daniel W. — Melbourne, 38, strength coach — Pulse + Wolverine

FAQ

Common Questions.

No — and the distinction matters. HGH (exogenous human growth hormone) replaces your own GH output, which suppresses your pituitary's natural production. Pulse stimulates your pituitary to produce more of your own GH — the hormone is endogenous, not synthetic. This preserves the pulsatile rhythm of natural GH release, which matters for the downstream effects. It also means your axis remains functional when you stop — no suppression, no crash.
Sleep improvement is typically the first signal — within 1–2 weeks. This is the slow-wave sleep restoration effect and it's direct, not downstream. Body composition changes follow at 4–6 weeks as IGF-1 accumulates. Recovery time between training sessions typically shortens in weeks 3–4. Pulse is not acute — it's a system being restored, not a stimulant.
This is one of our most popular stacks. Ipamorelin/CJC-1295 increases IGF-1, which accelerates the anabolic phase of tissue repair that BPC-157 initiates. The two compounds are mechanistically complementary — Wolverine drives the repair signal, Pulse amplifies the cellular resources available to carry it out. No known interactions.
Ipamorelin's side-effect profile is among the cleanest in the GH secretagogue class — no cortisol elevation, no prolactin spike. The most commonly reported effects are transient flushing and mild water retention in the first 1–2 weeks as the body adjusts to elevated GH. These typically resolve without intervention. Avoid administration within 2 hours of eating — carbohydrates blunt the GH pulse.
30-day full refund, no return required. The sleep improvement should be noticeable within 2 weeks — that's typically the first signal. If you don't notice improved sleep quality or recovery within 30 days, we return your $299. We compound at clinical dosing levels — if it's not working, something's wrong and we fix it.
Ships as lyophilised powder in a sterile vial. Reconstitute with bacteriostatic water using a fresh syringe and needle. Administer via subcutaneous injection — the lower abdomen or flank is the most common site. Rotate injection sites session to session. Ships stable at ambient temperature; refrigerate on arrival and use reconstituted solution within 21–28 days.
Standard workplace and roadside drug screens test for recreational substances and common medications — peptides will not appear on these screens. If you compete in a WADA-sanctioned sport, verify the current prohibited list at wada-ama.org before use, as regulations update annually. We recommend confirming with your sport's governing body before any sanctioned competition.